GERN
Geron Corp
Price:  
1.20 
USD
Volume:  
10,266,166.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN Relative Valuation

-274.7%
Upside

As of 2025-11-04, the Relative Valuation of Geron Corp (GERN) is (2.10) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.20 USD, the upside of Geron Corp based on Relative Valuation is -274.7%.

The range of the Relative Valuation is (1.53) - (2.60) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 10.0x - 18.8x 15.3x
Forward P/E multiples 11.1x - 21.9x 15.1x
Fair Price (1.53) - (2.60) (2.10)
Upside -227.6% - -316.3% -274.7%
1.20 USD
Stock Price
(2.10) USD
Fair Price

GERN Relative Valuation - Historical P/E Data

Date P/E
2025-10-31 -9.13
2025-10-30 -8.99
2025-10-29 -8.92
2025-10-28 -9.28
2025-10-27 -9.28
2025-10-24 -8.99
2025-10-23 -8.84
2025-10-22 -8.99
2025-10-21 -9.21
2025-10-20 -9.21
2025-10-17 -8.70
2025-10-16 -8.92
2025-10-15 -9.28
2025-10-14 -8.99
2025-10-13 -9.21
2025-10-10 -9.50
2025-10-09 -10.08
2025-10-08 -10.00
2025-10-07 -9.35
2025-10-06 -9.28
2025-10-03 -9.79
2025-10-02 -10.00
2025-10-01 -10.22
2025-09-30 -9.93
2025-09-29 -9.50
2025-09-26 -9.35
2025-09-25 -9.21
2025-09-24 -9.64
2025-09-23 -9.71
2025-09-22 -9.64
2025-09-19 -9.57
2025-09-18 -9.57
2025-09-17 -9.21
2025-09-16 -9.06
2025-09-15 -9.21
2025-09-12 -9.21
2025-09-11 -9.57
2025-09-10 -9.35
2025-09-09 -9.86
2025-09-08 -9.93
2025-09-05 -10.15
2025-09-04 -10.00
2025-09-03 -10.15
2025-09-02 -10.66
2025-08-29 -10.15
2025-08-28 -10.37
2025-08-27 -10.22
2025-08-26 -10.58
2025-08-25 -10.29
2025-08-22 -10.58